Mimicking the tumor microenvironment to regulate macrophage phenotype and assessing chemotherapeutic efficacy in embedded cancer cell/macrophage spheroid models
Source abstract
Abstract
Tumor associated macrophages (TAMs) are critical stromal components intimately involved with the progression, invasion, and metastasis of cancer cells. To address the need for an in vitro system that mimics the clinical observations of TAM localizations and subsequent functional performance, a cancer cell/macrophage spheroid model is described. The central component of the model is a triple negative breast cancer spheroid embedded in a three-dimensional collagen gel. Macrophages are incorporated in two different ways. The first is a heterospheroid, a spheroid containing both tumor cells and macrophages. The heterospheroid mimics the population of TAMs infiltrated into the tumor mass, thus being exposed to hypoxia and metabolic gradients. In the second model, macrophages are diffusely seeded in the collagen surrounding the spheroid, thus modeling TAMs in the cancer stroma. The inclusion of macrophages as a heterospheroid changes the metabolic profile, indicative of synergistic growth. In contrast, macrophages diffusely seeded in the collagen bear the same profile regardless of the presence of a tumor cell spheroid. The macrophages in the heterospheroid secrete EGF, a cytokine critical to tumor/macrophage co-migration, and an EGF inhibitor decreases the metabolic activity of the heterospheroid, which is not observed in the other systems. The increased secretion of IL-10 indicates that the heterospheroid macrophages follow an M2/TAM differentiation pathway. Lastly, the heterospheroid exhibits resistance to paclitaxel. In summary, the collagen embedded heterospheroid model promotes TAM-like characteristics, and will be of utility in cancer biology and drug discovery. Statement of significance Two in vitro collagen-embedded multicellular spheroid models are described that mimic the clinical observations of macrophage localization within a tumor. Incorporation of macrophages within a breast cancer spheroid emphasizes cell-cell interactions with subsequent differentiation toward a tumor-promoting TAM phenotype. In contrast, macrophages seeded around the tumor spheroid display decreased interaction with cancer cells and no indication of a TAM phenotype. Finally, the presence of macrophages in the heterospheroid increases resistance to paclitaxel. This study demonstrates that cell-cell interactions and 3D collagen matrix direct macrophage activity, and, thus, highlights the important role the local environment itself plays in macrophage behavior.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Immune cells in cancer · Cancer Cells and Metastasis · Mathematical Biology Tumor Growth
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies10.1083/jcb.137.1.231 ↗
2. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells
3. Quantitative analysis of the effect of cancer invasiveness and collagen concentration on 3D matrix remodeling10.1371/journal.pone.0024891 ↗
4. Stromal fibroblasts in cancer perspective a novel tumor-promoting cell type10.4161/cc.5.15.3112 ↗
5. Tumor-associated macrophages10.1016/0952-7915(90)90031-B ↗
6. T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression
7. Macrophage polarization in tumour progression10.1016/j.semcancer.2008.03.004 ↗
8. Angiogenic profile of breast carcinoma determines leukocyte infiltration10.1158/1078-0432.CCR-04-0742 ↗
9. High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer10.1371/journal.pone.0076147 ↗
10. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density
11. Macrophages, innate immunity and cancer: balance, tolerance, and diversity10.1016/j.coi.2010.01.009 ↗
12. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function10.1073/pnas.1210182109 ↗
13. Alternative activation of macrophages: an immunologic functional perspective10.1146/annurev.immunol.021908.132532 ↗
14. Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages10.1038/cr.2010.52 ↗
15. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility10.4049/jimmunol.1000413 ↗
16. Macrophages define the invasive microenvironment in breast cancer10.1189/jlb.1107762 ↗
17. Growth of multicell spheroids in tissue culture as a model of nodular carcinomas
18. Experimental anti-tumor therapy in 3-D: spheroids – old hat or new challenge?10.1080/09553000701727531 ↗
19. Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles10.7150/thno.3568 ↗
20. Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance10.1016/j.actbio.2005.04.003 ↗
21. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts10.1016/j.imbio.2010.05.019 ↗
22. A cellular trojan horse for delivery of therapeutic nanoparticles into tumors10.1021/nl072209h ↗
23. Macrophages promote angiogenesis in human breast tumour spheroids in vivo10.1038/sj.bjc.6602901 ↗
24. Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration
25. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors10.1158/0008-5472.CAN-06-1823 ↗
26. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland10.1002/dvdy.20972 ↗
27. Embedded multicellular spheroids as a biomimetic 3D cancer model for evaluating drug and drug-device combinations10.1016/j.biomaterials.2013.11.038 ↗
28. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis10.1177/1087057106292763 ↗
29. NIH Image to ImageJ: 25years of image analysis10.1038/nmeth.2089 ↗
30. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells10.1074/jbc.275.12.8806 ↗
31. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations10.1038/modpathol.3800438 ↗
32. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231)10.1002/ijc.22187 ↗
33. M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway10.1038/labinvest.2013.69 ↗
34. Distinct role of macrophages in different tumor microenvironments10.1158/0008-5472.CAN-05-4005 ↗
35. Macrophage responses to hypoxia implications for tumor progression and anti-cancer therapies10.1016/S0002-9440(10)62038-X ↗
36. Islet oxygen consumption rate (OCR) dose predicts insulin independence in clinical islet autotransplantation10.1371/journal.pone.0134428 ↗
37. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy10.1053/j.seminoncol.2004.03.040 ↗
38. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop10.1158/0008-5472.CAN-04-1853 ↗
39. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors a paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors10.1158/0008-5472.CAN-04-1449 ↗
40. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients
41. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy10.1007/s12026-011-8262-6 ↗
42. The effect of surface roughness on RAW 264.7 macrophage phenotype10.1002/jbm.a.34562 ↗
43. Altering in vivo macrophage responses with modified polymer properties10.1016/j.biomaterials.2015.03.042 ↗
44. Macrophage regulation of tumor responses to anticancer therapies10.1016/j.ccr.2013.02.013 ↗
45. Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer10.1038/cdd.2013.67 ↗
46. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF10.1016/j.ccr.2010.11.009 ↗
47. Role of macrophage targeting in the antitumor activity of trabectedin10.1016/j.ccr.2013.01.008 ↗
48. Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses10.1158/0008-5472.CAN-12-2731 ↗
49. Macrophage diversity enhances tumor progression and metastasis10.1016/j.cell.2010.03.014 ↗